prednisone has been researched along with Cystic Fibrosis of Pancreas in 49 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated growth six to seven years after alternate-day treatment with prednisone had been discontinued in 224 children 6 to 14 years of age with cystic fibrosis who had participated in a multicenter trial of this therapy from 1986 through 1991." | 9.09 | Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. ( Allen, DB; Campbell, PW; Farrell, PM; FitzSimmons, SC; Kosorok, MR; Lai, HC; Rosenstein, BJ, 2000) |
| "The purpose of this study was to evaluate the efficacy and safety of alternate-day prednisone therapy in treating patients with mild-to-moderate cystic fibrosis during a 4-year period." | 9.08 | A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. ( Eigen, H; FitzSimmons, S; Rosenstein, BJ; Schidlow, DV, 1995) |
| "A randomised, double-blind, placebo-controlled study examined the effects of alternate-day prednisone therapy on morbidity and progression of lung disease in cystic fibrosis (CF)." | 9.05 | Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. ( Auerbach, HS; Colten, HR; Kirkpatrick, JA; Williams, M, 1985) |
| "We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age." | 7.74 | Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. ( Anbar, RD; Awa, E; Santos, RP, 2007) |
| " She had undergone a lung transplantation because of cystic fibrosis and was receiving maintenance treatment with tacrolimus and prednisone." | 7.72 | Acute headache as a presenting symptom of tacrolimus encephalopathy. ( de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J, 2003) |
| "(1) To determine the relationship between IgE levels and the prevalence of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients, (2) to establish the usefulness of assessing atopy as an identifying risk factor for ABPA, (3) to evaluate the clinical course of patients receiving and not receiving itraconazole as reflected in oral steroid dose requirements and number of acute episodes of ABPA, and (4) to determine the role of acute episodes of ABPA in pulmonary exacerbations of CF." | 7.70 | Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. ( Esrig, S; Moss, RB; Nepomuceno, IB, 1999) |
| "Prednisolone pharmacokinetics were evaluated in eight patients with cystic fibrosis (CF) (aged 1." | 7.68 | Altered prednisolone pharmacokinetics in patients with cystic fibrosis. ( Accurso, FJ; Dove, AM; Hill, MR; Jusko, WJ; Larsen, GL; Szefler, SJ, 1992) |
| "We hypothesized that adding 5 days of prednisone to standard therapy for acute pulmonary exacerbations in patients with cystic fibrosis (CF) would result in a more rapid and greater increase in lung function." | 5.12 | Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study. ( Aitken, ML; Dovey, M; Emerson, J; Gibson, RL; McNamara, S; Waltz, DA, 2007) |
| "We evaluated growth six to seven years after alternate-day treatment with prednisone had been discontinued in 224 children 6 to 14 years of age with cystic fibrosis who had participated in a multicenter trial of this therapy from 1986 through 1991." | 5.09 | Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. ( Allen, DB; Campbell, PW; Farrell, PM; FitzSimmons, SC; Kosorok, MR; Lai, HC; Rosenstein, BJ, 2000) |
| "The purpose of this study was to evaluate the efficacy and safety of alternate-day prednisone therapy in treating patients with mild-to-moderate cystic fibrosis during a 4-year period." | 5.08 | A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. ( Eigen, H; FitzSimmons, S; Rosenstein, BJ; Schidlow, DV, 1995) |
| "A randomised, double-blind, placebo-controlled study examined the effects of alternate-day prednisone therapy on morbidity and progression of lung disease in cystic fibrosis (CF)." | 5.05 | Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. ( Auerbach, HS; Colten, HR; Kirkpatrick, JA; Williams, M, 1985) |
| "We report a patient with CF who developed recurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative-free tobramycin by inhalation, beginning at 16 months of age." | 3.74 | Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. ( Anbar, RD; Awa, E; Santos, RP, 2007) |
| " She had undergone a lung transplantation because of cystic fibrosis and was receiving maintenance treatment with tacrolimus and prednisone." | 3.72 | Acute headache as a presenting symptom of tacrolimus encephalopathy. ( de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J, 2003) |
| "(1) To determine the relationship between IgE levels and the prevalence of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients, (2) to establish the usefulness of assessing atopy as an identifying risk factor for ABPA, (3) to evaluate the clinical course of patients receiving and not receiving itraconazole as reflected in oral steroid dose requirements and number of acute episodes of ABPA, and (4) to determine the role of acute episodes of ABPA in pulmonary exacerbations of CF." | 3.70 | Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. ( Esrig, S; Moss, RB; Nepomuceno, IB, 1999) |
| "Prednisolone pharmacokinetics were evaluated in eight patients with cystic fibrosis (CF) (aged 1." | 3.68 | Altered prednisolone pharmacokinetics in patients with cystic fibrosis. ( Accurso, FJ; Dove, AM; Hill, MR; Jusko, WJ; Larsen, GL; Szefler, SJ, 1992) |
| " Three patients had underlying cystic fibrosis, and three had severe asthma; four of the six required continuous high-dose systemic prednisone (mean, 43 mg/day; confidence interval [CI], 23 to 63 mg/day) at the start of therapy." | 3.68 | Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. ( Denning, DW; Lewiston, NJ; Stevens, DA; Van Wye, JE, 1991) |
| " Fifteen patients with cystic fibrosis treated at Duke University Medical Center between January 1982 and October 1987 required prednisone for treatment of allergic bronchopulmonary aspergillosis (ABPA)." | 3.67 | Risk factors for the development of posterior subcapsular cataracts in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis treated with corticosteroids. ( Majure, M; Mroueh, S; Spock, A, 1989) |
| "Cystic fibrosis is a recessive, fatal genetic disease involving multiple organ systems, in which patients develop pancreatic insufficiency, malabsorption, and repeated pulmonary infections." | 2.38 | Pharmacologic management of cystic fibrosis. ( Hall, M; Kuhn, RJ; Wallace, CS, 1993) |
| "Three children developed allergic bronchopulmonary aspergillosis (ABPA) as a complication of either asthma or cystic fibrosis (CF)." | 1.33 | [Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis]. ( Dompeling, E; Hendriks, JJ; Jöbsis, Q; van Hoorn, JH, 2005) |
| "A case of allergic bronchopulmonary Aspergillosis (ABPA) complicating lung transplantation for cystic fibrosis is described." | 1.31 | Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin. ( Casey, P; Eaton, T; Garrett, J, 2002) |
| "The authors report two cases of allergic bronchopulmonary aspergillosis complicating cystic fibrosis in adults: respectively an acute and an exacerbation stage." | 1.29 | [Allergic bronchopulmonary aspergillosis and cystic fibrosis. 2 case reports in adults]. ( Bildstein, F; Dalphin, JC; Debieuvre, D; Depierre, A; Estavoyer, JM; Leroy, J, 1993) |
| "In order to determine the incidence of allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF), we reviewed the records of 236 patients followed up at the Duke CF Center." | 1.29 | Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. ( Mroueh, S; Spock, A, 1994) |
| "Osteoporosis and vitamin D deficiency are extremely common in patients with end-stage pulmonary disease." | 1.29 | Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. ( Addesso, V; Donovan, D; Jorgesen, B; McGregor, C; Papadopoulos, A; Schulman, L; Shane, E; Silverberg, SJ; Staron, RB, 1996) |
| "Three had cor pulmonale, as evidenced by echocardiogram, and all had baseline tachycardia." | 1.27 | Supraventricular tachycardia in patients with cystic fibrosis. ( Hindi, RD; Lewiston, NJ; Moss, RB; Sullivan, MM, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (22.45) | 18.7374 |
| 1990's | 15 (30.61) | 18.2507 |
| 2000's | 14 (28.57) | 29.6817 |
| 2010's | 6 (12.24) | 24.3611 |
| 2020's | 3 (6.12) | 2.80 |
| Authors | Studies |
|---|---|
| Filipow, N | 1 |
| Stanojevic, S | 1 |
| Raywood, E | 1 |
| Shannon, H | 1 |
| Tanriver, G | 1 |
| Kapoor, K | 1 |
| Douglas, H | 1 |
| Davies, G | 1 |
| O'Connor, R | 1 |
| Murray, N | 1 |
| Main, E | 1 |
| Gothe, F | 1 |
| Schmautz, A | 1 |
| Häusler, K | 1 |
| Tran, NB | 1 |
| Kappler, M | 1 |
| Griese, M | 1 |
| Singh, H | 1 |
| Borro, JM | 1 |
| Rama, P | 1 |
| Rey, T | 1 |
| Fernández-Rivera, C | 1 |
| Tikotekar, A | 1 |
| Jagpal, S | 1 |
| Nagella, N | 1 |
| Delgado Pecellín, I | 1 |
| Quintana Gallego, E | 1 |
| Pedregal Solano, C | 1 |
| Calero Acuña, C | 1 |
| Bugano, DD | 1 |
| Campos, SV | 1 |
| Afonso, JE | 1 |
| Caramori, ML | 1 |
| Teixeira, RH | 1 |
| Carraro, RM | 1 |
| Strabelli, TM | 1 |
| Machado, CM | 1 |
| Samano, MN | 1 |
| Pêgo-Fernandes, P | 1 |
| Jatene, FB | 1 |
| Ghdifan, S | 1 |
| Couderc, L | 1 |
| Michelet, I | 1 |
| Leguillon, C | 1 |
| Masseline, B | 1 |
| Marguet, C | 1 |
| Dopfer, C | 1 |
| Kentouche, K | 1 |
| Gruhn, B | 1 |
| Dopfer, R | 1 |
| Becker, S | 1 |
| Mentzel, HJ | 1 |
| Beck, JF | 1 |
| Mainz, JG | 1 |
| Yen, D | 1 |
| Hedden, D | 1 |
| Casey, P | 1 |
| Garrett, J | 1 |
| Eaton, T | 1 |
| Aebischer, CC | 1 |
| Schöni, MH | 1 |
| Kiemeneij, IM | 1 |
| de Leeuw, FE | 1 |
| Ramos, LM | 1 |
| van Gijn, J | 1 |
| Navascués, RA | 1 |
| Vidau, P | 1 |
| Palacios, L | 1 |
| Pousa, M | 1 |
| BODIAN, M | 1 |
| SHELDON, W | 1 |
| LIGHTWOOD, R | 1 |
| REID, L | 1 |
| Lukela, M | 1 |
| DeGuzman, D | 1 |
| Weinberger, S | 1 |
| Saint, S | 1 |
| van Hoorn, JH | 1 |
| Hendriks, JJ | 1 |
| Dompeling, E | 1 |
| Jöbsis, Q | 1 |
| Santos, RP | 1 |
| Awa, E | 1 |
| Anbar, RD | 1 |
| Dovey, M | 1 |
| Aitken, ML | 2 |
| Emerson, J | 1 |
| McNamara, S | 1 |
| Waltz, DA | 1 |
| Gibson, RL | 1 |
| Bush, A | 1 |
| Davies, J | 1 |
| Zirbes, JM | 1 |
| Milla, CE | 1 |
| Götz, M | 1 |
| Eigen, H | 2 |
| Rosenstein, BJ | 3 |
| FitzSimmons, S | 1 |
| Schidlow, DV | 1 |
| Gururangan, S | 1 |
| Horner, M | 1 |
| Rodman, JH | 1 |
| Marina, NM | 1 |
| Debieuvre, D | 1 |
| Dalphin, JC | 1 |
| Leroy, J | 1 |
| Estavoyer, JM | 1 |
| Bildstein, F | 1 |
| Depierre, A | 1 |
| Mroueh, S | 2 |
| Spock, A | 2 |
| Wallace, CS | 1 |
| Hall, M | 1 |
| Kuhn, RJ | 1 |
| Shane, E | 1 |
| Silverberg, SJ | 1 |
| Donovan, D | 1 |
| Papadopoulos, A | 1 |
| Staron, RB | 1 |
| Addesso, V | 1 |
| Jorgesen, B | 1 |
| McGregor, C | 1 |
| Schulman, L | 1 |
| Konstan, MW | 1 |
| Döring, G | 1 |
| Altemeier, WA | 1 |
| Tonelli, MR | 1 |
| Nepomuceno, IB | 1 |
| Esrig, S | 1 |
| Moss, RB | 2 |
| Lai, HC | 1 |
| FitzSimmons, SC | 1 |
| Allen, DB | 1 |
| Kosorok, MR | 1 |
| Campbell, PW | 1 |
| Farrell, PM | 1 |
| Davis, PB | 1 |
| Kercsmar, CM | 1 |
| Oermann, CM | 1 |
| Paulsen, EP | 1 |
| Koury, M | 1 |
| Thompson, AB | 1 |
| Smits, WL | 1 |
| Fick, RB | 1 |
| Dove, AM | 1 |
| Szefler, SJ | 1 |
| Hill, MR | 1 |
| Jusko, WJ | 1 |
| Larsen, GL | 1 |
| Accurso, FJ | 1 |
| Denning, DW | 1 |
| Van Wye, JE | 1 |
| Lewiston, NJ | 2 |
| Stevens, DA | 1 |
| Paty, E | 1 |
| Kramkinel, J | 1 |
| de Montalembert, M | 1 |
| Lenoir, G | 1 |
| Paupe, J | 1 |
| de Blic, J | 1 |
| Scheinmann, P | 1 |
| Sullivan, MM | 1 |
| Hindi, RD | 1 |
| Majure, M | 1 |
| Auerbach, HS | 1 |
| Williams, M | 1 |
| Kirkpatrick, JA | 1 |
| Colten, HR | 1 |
| Brett, MM | 1 |
| Ghoneim, AT | 1 |
| Littlewood, JM | 1 |
| Gall, DG | 1 |
| Hamilton, JR | 1 |
| Lloyd-Still, JD | 1 |
| Khaw, KT | 1 |
| Shwachman, H | 1 |
| Friedland, GW | 1 |
| Yamate, M | 1 |
| Marinkovich, VA | 1 |
6 reviews available for prednisone and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Pharmacologic management of cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchodilator Agents; Child; Cimetidine; Cystic Fibrosis; | 1993 |
Treatment of airway inflammation in cystic fibrosis.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Anti-Inf | 1996 |
Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
Topics: alpha 1-Antitrypsin; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammat | 2001 |
Immunomodulatory therapies for cystic fibrosis.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Expectorants; Humans; Ibuprofen; Immunotherapy; Interferon-g | 1992 |
[Mucoviscidosis and allergic bronchopulmonary aspergillosis].
Topics: Adolescent; Adult; Aspergillosis, Allergic Bronchopulmonary; Child; Child, Preschool; Cystic Fibrosi | 1991 |
Chronic diarrhea in childhood: a new look at an old problem.
Topics: Celiac Disease; Chlorides; Chronic Disease; Cystic Fibrosis; Diarrhea; Diet Therapy; Food Hypersensi | 1974 |
6 trials available for prednisone and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study.
Topics: Adult; Cystic Fibrosis; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; | 2007 |
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.
Topics: Adolescent; Analysis of Variance; Child; Cystic Fibrosis; Double-Blind Method; Drug Administration S | 1995 |
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
Topics: Adolescent; Body Height; Body Weight; Child; Cystic Fibrosis; Double-Blind Method; Drug Administrati | 2000 |
[Mucoviscidosis and allergic bronchopulmonary aspergillosis].
Topics: Adolescent; Adult; Aspergillosis, Allergic Bronchopulmonary; Child; Child, Preschool; Cystic Fibrosi | 1991 |
Risks of alternate-day prednisone in patients with cystic fibrosis.
Topics: Child; Cystic Fibrosis; Drug Administration Schedule; Humans; Prednisone | 1991 |
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.
Topics: Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Double | 1985 |
38 other studies available for prednisone and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Real-world effectiveness of airway clearance techniques in children with cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Forced Expiratory Volume; Humans; Linear Models; Prednisone; Spu | 2023 |
Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.
Topics: Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Cystic Fibrosis; Humans; Itraconazo | 2020 |
Light at the End of Tunnel-Managing Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Topics: Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Cystic Fibrosis; Humans; Itraconazo | 2020 |
Long-term success of combined kidney-lung transplantation in a patient with cystic fibrosis.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Basiliximab; Coinfection; Cystic Fibrosis; Graft Rejec | 2013 |
A clinical prediction tool for prognosis in patients with cystic fibrosis, short-term glucocorticoid therapy for chronic obstructive pulmonary disease, and laryngeal ultrasound for prediction of postextubation laryngeal edema.
Topics: Cystic Fibrosis; Decision Support Techniques; Female; Glucocorticoids; Humans; Lung; Male; Prednison | 2014 |
[Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
Topics: Adolescent; Adult; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antifungal Agents; | 2015 |
Impact of cytomegalovirus infection in lung transplant patients under universal prophylaxis: single-center experience in Brazil.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Brazil; Bronchiectasis; Cohort Studies; Cy | 2010 |
Bolus methylprednisolone efficacy for uncontrolled exacerbation of cystic fibrosis in children.
Topics: Anti-Inflammatory Agents; Bronchiectasis; Child; Combined Modality Therapy; Cystic Fibrosis; Disease | 2010 |
Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Comorbidity; Cystic Fi | 2011 |
Multiple vertebral compression fractures in a patient treated with corticosteroids for cystic fibrosis.
Topics: Adolescent; Anti-Inflammatory Agents; Casts, Surgical; Cystic Fibrosis; Fatal Outcome; Fractures, Sp | 2002 |
Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin.
Topics: Administration, Inhalation; Adult; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronch | 2002 |
[Cystic fibrosis: current therapy. Allergic bronchopulmonary aspergillosis (ABPA)].
Topics: Aspergillosis, Allergic Bronchopulmonary; Cystic Fibrosis; Humans; Itraconazole; Prednisone | 2000 |
Acute headache as a presenting symptom of tacrolimus encephalopathy.
Topics: Acute Disease; Adult; Brain; Brain Diseases; Cyclosporine; Cystic Fibrosis; Diagnosis, Differential; | 2003 |
[Purpura de Schonlein-Henoch in patient with fibrosis qistica].
Topics: Adult; Cystic Fibrosis; Female; Glucocorticoids; Humans; IgA Vasculitis; Prednisone; Treatment Outco | 2003 |
CONGENITAL HYPOPLASIA OF THE EXOCRINE PANCREAS.
Topics: Agranulocytosis; Anemia; Biopsy; Child; Congenital Abnormalities; Cystic Fibrosis; Genetics, Medical | 1964 |
HISTOCHEMICAL AND ENZYME STUDIES OF BRONCHIAL MUCUS.
Topics: Asthma; Bronchi; Bronchitis; Cystic Fibrosis; Glycosaminoglycans; Histocytochemistry; Humans; Mucous | 1965 |
Clinical problem-solving. Unfashionably late.
Topics: Adolescent; Biopsy; Burkholderia cepacia; Burkholderia Infections; Chest Pain; Chlorides; Cough; Cys | 2005 |
[Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis].
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Cystic Fibrosis; Di | 2005 |
Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report.
Topics: Administration, Inhalation; Bronchial Spasm; Child, Preschool; Cystic Fibrosis; Dose-Response Relati | 2007 |
Non! to non-steroidal anti-inflammatory therapy for inflammatory lung disease in cystic fibrosis (at least at the moment).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Cystic Fibrosis; Humans; Ibuprofen; Prednisone | 2007 |
Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
Topics: Adolescent; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Mo | 2008 |
[Obstructive airway diseases in children].
Topics: Abscess; Adult; Asthma; Child; Child, Preschool; Cystic Fibrosis; Foreign-Body Reaction; Humans; Inh | 1982 |
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cyt | 1994 |
[Allergic bronchopulmonary aspergillosis and cystic fibrosis. 2 case reports in adults].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disea | 1993 |
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Ast | 1994 |
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Bone Density; Cystic Fibrosis; Female; Fractures, S | 1996 |
Anti-inflammatory therapy.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; | 1997 |
Pseudomonal pericarditis complicating cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Cystic Fibrosis; Disease Progression; Drainage; Fatal Outcome; Huma | 1999 |
Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child | 1999 |
Growth in children with chronic lung disease.
Topics: Administration, Inhalation; Asthma; Body Height; Child; Cystic Fibrosis; Glucocorticoids; Growth; Gr | 2000 |
Hemoglobin AIc levels in insulin-dependent and -independent diabetes mellitus.
Topics: Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, T | 1976 |
Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
Topics: Administration, Oral; Asthma; Biological Availability; Child; Cystic Fibrosis; Humans; Infusions, In | 1992 |
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Cystic Fibro | 1991 |
Supraventricular tachycardia in patients with cystic fibrosis.
Topics: Adult; Bronchodilator Agents; Cardiac Complexes, Premature; Child; Cystic Fibrosis; Echocardiography | 1986 |
Risk factors for the development of posterior subcapsular cataracts in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis treated with corticosteroids.
Topics: Adolescent; Adult; Aspergillosis, Allergic Bronchopulmonary; Body Height; Cataract; Child; Child, Pr | 1989 |
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Child; Child, | 1988 |
Severe respiratory disease in infants with cystic fibrosis.
Topics: Acidosis; Acidosis, Respiratory; Anti-Bacterial Agents; Autopsy; Cystic Fibrosis; Escherichia coli I | 1974 |
Hiatal hernia and chronic unremitting asthma.
Topics: Adolescent; Age Factors; Asthma; Body Height; Body Weight; Child; Child, Preschool; Chronic Disease; | 1973 |